Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2015 Jun;30(7):919-27.
doi: 10.1002/mds.26170. Epub 2015 Mar 4.

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

Daniel Weintraub  1 , Tanya Simuni  2 , Chelsea Caspell-Garcia  3 , Christopher Coffey  3 , Shirley Lasch  4 , Andrew Siderowf  5 , Dag Aarsland  6 , Paolo Barone  7 , David Burn  8 , Lama M Chahine  9 , Jamie Eberling  10 , Alberto J Espay  11 , Eric D Foster  3 , James B Leverenz  12 , Irene Litvan  13 , Irene Richard  14 , Matthew D Troyer  15 , Keith A Hawkins  16 ; Parkinson's Progression Markers Initiative
Affiliations
Multicenter Study

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

Daniel Weintraub et al. Mov Disord. 2015 Jun.

Abstract

This study was undertaken to determine the prevalence and correlates of cognitive impairment (CI) and neuropsychiatric symptoms (NPS) in early, untreated patients with Parkinson's disease (PD).

Background: Both CI and NPS are common in PD and impact disease course and quality of life. However, limited knowledge is available about cognitive abilities and NPS.

Methods: Parkinson's Progression Markers Initiative (PPMI) is a multi-site study of early, untreated PD patients and healthy controls (HCs), the latter with normal cognition. At baseline, participants were assessed with a neuropsychological battery and for symptoms of depression, anxiety, impulse control disorders (ICDs), psychosis, and apathy.

Results: Baseline data of 423 PD patients and 196 HCs yielded no between-group differences in demographic characteristics. Twenty-two percent of PD patients met the PD-recommended screening cutoff for CI on the Montral Cognitive Assessment (MoCA), but only 9% met detailed neuropsychological testing criteria for mild cognitive impairment (MCI)-level impairment. The PD patients were more depressed than HCs (P < 0.001), with twice as many (14% vs. 7%) meeting criteria for clinically significant depressive symptoms. The PD patients also experienced more anxiety (P < 0.001) and apathy (P < 0.001) than HCs. Psychosis was uncommon in PD (3%), and no between-group difference was seen in ICD symptoms (P = 0.51).

Conclusions: Approximately 10% of PD patients in the early, untreated disease state met traditional criteria of CI, which is a lower frequency compared with previous studies. Multiple dopaminergic-dependent NPS are also more common in these patients compared with the general population, but others associated with dopamine replacement therapy are not or are rare. Future analyses of this cohort will examine biological predictors and the course of CI and NPS. © 2015 International Parkinson and Movement Disorder Society.

Keywords: Parkinson's disease; anxiety; apathy; cognition; depression; impulse control disorder; psychosis.

PubMed Disclaimer

Conflict of interest statement

Relevant conflicts of interest/financial disclosures: Nothing to report.

Full financial disclosures and author roles may be found in the online version of this article.

References

    1. Weintraub D, Burn DJ. Parkinson’s disease: the quintessential neuropsychiatric disorder. Mov Disord. 2011;26:1022–1031. - PMC - PubMed
    1. Aarsland D, Bronnick K, Williams-Gray CH, et al. Mild cognitive impairment in Parkinson’s disease: a multicenter pooled analysis. Neurology. 2010;75:1062–1069. - PMC - PubMed
    1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60:387–392. - PubMed
    1. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G, ParkWest Study Group Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study. Neurology. 2009;72:1121–1126. - PubMed
    1. Foltynie T, Brayne C, Robbins T, Barker R. The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study Brain. 2004;127:550–560. - PubMed

Publication types

MeSH terms